SWOG clinical trial number
SWOG-8209

A Study of AZQ (aziridinylbenzoquinone) in Soft Tissue and Bony Sarcomas

Closed
Phase
Published
Abbreviated Title
A Study of AZQ (aziridinylbenzoquinone) in Soft Tissue and Bony Sarcomas
Activated
08/25/1982
Closed
05/27/1983

Publication Information Expand/Collapse

1985

A Phase II study of aziridinylbenzoquinone (AZQ) in advanced soft tissue and bony sarcoma: A Southwest Oncology Group study.

BL Zidar;LH Baker;SE Rivkin;SP Balcerzak;RL Stephens Cancer Treat Rep 69(9):1305-1306

A Phase II study of aziridinylbenzoquinone (AZQ) in advanced soft tissue and bony sarcoma. A Southwest Oncology Group study.

B Zidar;L Baker;S Rivkin;S Balcerzak;R Stephens ASCO :#C-505